Remimazolam tosylate - Jiangsu Hengrui Medicine Co.Alternative Names: HR-7056; Remimazolam tosilate
Latest Information Update: 30 Dec 2016
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class Benzodiazepines; Hypnosedatives; Small molecules
- Mechanism of Action GABA A receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Anaesthesia; Sedation
- Phase I Insomnia
Most Recent Events
- 01 Nov 2016 Phase-II clinical trials in Sedation in China (IV) (NCT03003884)
- 01 Dec 2014 Phase-II clinical trials in Anaesthesia in China (IV)
- 01 Oct 2013 Phase-I clinical trials in Insomnia in China (IV)